HOME > ARCHIVE
ARCHIVE
- Japan's Pacemaker Market Growing Around 10% Annually
November 17, 2003
- Fujisawa's Overseas Sales Exceed 50% of Total
November 17, 2003
- BULLETIN
November 17, 2003
- Semiannual Business Results
November 17, 2003
- MPC New Plan Aiming at Sales of \240 Bil. in FY2006: President Kobori
November 17, 2003
- REGULATORY NEWS IN BRIEF
November 17, 2003
- Sanki Aiming for 25% Share of Chugoku Market in 5 Years
November 10, 2003
- BUSINESS NEWS IN BRIEF
November 10, 2003
- Cataract Surgery Reduces Medical Costs: Mr Akedo of ILSAJ
November 10, 2003
- Korosho Study Group Analyzes Useful Factors for Predicting Drug Responses
November 10, 2003
- REGULATORY NEWS IN BRIEF
November 10, 2003
- Support for Bungyo Stronger in Patients Who Have Experienced It
November 10, 2003
- MEDICAL DEVICE NEWS IN BRIEF
November 10, 2003
- BULLETIN
November 10, 2003
- WORLD NEWS IN BRIEF
November 10, 2003
- MEDICAL FACILITIES & NURSING CARE NEWS IN BRIEF
November 10, 2003
- Japanese Healthcare Q&A (3)
November 10, 2003
- Hayashibara Develops Peptide Antigens for Transmucosal Administration
November 10, 2003
- Nearly 70% of Women Worry about Adverse Reactions of Oral Contraceptives
November 10, 2003
- Long-term Monitoring Required after H. Pylori Eradication
November 10, 2003
ページ
In the complex landscape of the Japanese pharmaceutical market, the “status quo” is often the safest harbor. But for leaders like Kennet Brysting, former president of Gilead Japan, the status quo is the most dangerous place to stay.Innovation in Japan…
